Literature DB >> 18458309

Human IgG antibody response to Glossina saliva: an epidemiologic marker of exposure to Glossina bites.

Anne Poinsignon1, Franck Remoue, Marie Rossignol, Sylvie Cornelie, David Courtin, Pascal Grébaut, Andre Garcia, Francois Simondon.   

Abstract

The evaluation of human antibody response specific to arthropod saliva may be a useful marker of exposure to vector-borne disease. Such an immunologic tool, applied to the evaluation of the exposure to Glossina bites, could be integrated in the control of human African trypanosomiasis (HAT). The antibody (IgG) response specific to uninfected Glossina fuscipes fuscipes saliva was evaluated according to the vector exposure and trypanic status in individuals residing in an HAT-endemic area. A high level of anti-saliva IgG antibodies was only detected in exposed individuals, whether infected or not by Trypanosoma brucei gambiense. In addition, the evaluation of specific IgG response represented spatial heterogeneity according to studied sites. These results suggest that the evaluation of anti-saliva IgG could be an indicator of Glossina exposure and thus could be integrated in other available tools to identify populations presenting risks of HAT transmission.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18458309

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  28 in total

1.  Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.

Authors:  Papa M Drame; Anne Poinsignon; Patrick Besnard; Jacques Le Mire; Maria A Dos-Santos; Cheikh S Sow; Sylvie Cornelie; Vincent Foumane; Jean-Claude Toto; Mbacké Sembene; Denis Boulanger; François Simondon; Filomeno Fortes; Pierre Carnevale; Franck Remoue
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis.

Authors:  Soumaya Marzouki; Mélika Ben Ahmed; Thouraya Boussoffara; Maha Abdeladhim; Nissaf Ben Aleya-Bouafif; Abdelkader Namane; Nabil Belhaj Hamida; Afif Ben Salah; Hechmi Louzir
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

3.  Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.

Authors:  Souleymane Doucoure; François Mouchet; Amandine Cournil; Gilbert Le Goff; Sylvie Cornelie; Yelin Roca; Mabel Guerra Giraldez; Zaira Barja Simon; Roxanna Loayza; Dorothée Misse; Jorge Vargas Flores; Annie Walter; Christophe Rogier; Jean Pierre Herve; Franck Remoue
Journal:  Am J Trop Med Hyg       Date:  2012-07-30       Impact factor: 2.345

4.  Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America.

Authors:  Clarissa Teixeira; Regis Gomes; Nicolas Collin; David Reynoso; Ryan Jochim; Fabiano Oliveira; Amy Seitz; Dia-Eldin Elnaiem; Arlene Caldas; Ana Paula de Souza; Cláudia I Brodskyn; Camila Indiani de Oliveira; Ivete Mendonca; Carlos H N Costa; Petr Volf; Aldina Barral; Shaden Kamhawi; Jesus G Valenzuela
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

5.  Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice.

Authors:  Srdjan M Dragovic; Tolulope A Agunbiade; Marianna Freudzon; Jing Yang; Andrew K Hastings; Tyler R Schleicher; Xia Zhou; Sam Craft; Yu-Min Chuang; Floricel Gonzalez; Youquan Li; Gabriela Hrebikova; Abhai Tripathi; Godfree Mlambo; Lionel Almeras; Alexander Ploss; George Dimopoulos; Erol Fikrig
Journal:  Cell Host Microbe       Date:  2018-04-11       Impact factor: 21.023

6.  Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.

Authors:  Phubeth Ya-Umphan; Dominique Cerqueira; Gilles Cottrell; Daniel M Parker; Freya J I Fowkes; Francois Nosten; Vincent Corbel
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

7.  First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.

Authors:  Emmanuel Elanga Ndille; Souleymane Doucoure; Georgia Damien; François Mouchet; Papa Makhtar Drame; Sylvie Cornelie; Herbert Noukpo; Sandra Yamadjako; Armel Djenontin; Nicolas Moiroux; Dorothee Misse; Martin Akogbeto; Vincent Corbel; Marie-Claire Henry; Fabrice Chandre; Thierry Baldet; Franck Remoue
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

8.  IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.

Authors:  Papa M Drame; Vanessa Machault; Abdoulaye Diallo; Sylvie Cornélie; Anne Poinsignon; Richard Lalou; Mbacké Sembène; Stéphanie Dos Santos; Christophe Rogier; Frédéric Pagès; Jean-Yves Le Hesran; Franck Remoué
Journal:  Malar J       Date:  2012-03-16       Impact factor: 2.979

9.  Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.

Authors:  Anne Poinsignon; Sylvie Cornelie; Fatou Ba; Denis Boulanger; Cheikh Sow; Marie Rossignol; Cheikh Sokhna; Badara Cisse; François Simondon; Franck Remoue
Journal:  Malar J       Date:  2009-08-13       Impact factor: 2.979

10.  Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans.

Authors:  Soumaya Marzouki; Maha Abdeladhim; Chaouki Ben Abdessalem; Fabiano Oliveira; Beya Ferjani; Dana Gilmore; Hechmi Louzir; Jesus G Valenzuela; Mélika Ben Ahmed
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.